IL132443A0 - Human cerberus protein - Google Patents

Human cerberus protein

Info

Publication number
IL132443A0
IL132443A0 IL13244398A IL13244398A IL132443A0 IL 132443 A0 IL132443 A0 IL 132443A0 IL 13244398 A IL13244398 A IL 13244398A IL 13244398 A IL13244398 A IL 13244398A IL 132443 A0 IL132443 A0 IL 132443A0
Authority
IL
Israel
Prior art keywords
human cerberus
cerberus protein
protein
human
cerberus
Prior art date
Application number
IL13244398A
Other languages
English (en)
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26721541&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL132443(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of IL132443A0 publication Critical patent/IL132443A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL13244398A 1997-04-29 1998-03-31 Human cerberus protein IL132443A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4442797P 1997-04-29 1997-04-29
US4515797P 1997-04-30 1997-04-30
PCT/US1998/006324 WO1998049296A1 (en) 1997-04-29 1998-03-31 Human cerberus protein

Publications (1)

Publication Number Publication Date
IL132443A0 true IL132443A0 (en) 2001-03-19

Family

ID=26721541

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13244398A IL132443A0 (en) 1997-04-29 1998-03-31 Human cerberus protein

Country Status (8)

Country Link
US (2) US6610510B1 (enExample)
EP (1) EP0975752A1 (enExample)
JP (1) JP4062551B2 (enExample)
AU (1) AU726385B2 (enExample)
CA (1) CA2288373C (enExample)
IL (1) IL132443A0 (enExample)
NZ (1) NZ500577A (enExample)
WO (1) WO1998049296A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150328A (en) 1986-07-01 2000-11-21 Genetics Institute, Inc. BMP products
US6291206B1 (en) 1993-09-17 2001-09-18 Genetics Institute, Inc. BMP receptor proteins
EP0733109B9 (en) 1993-12-07 2006-07-05 Genetics Institute, LLC Bmp-12, bmp-13 and tendon-inducing compositions thereof
WO1999061044A1 (en) * 1998-05-28 1999-12-02 The Board Of Trustees Of The University Of Arkansas Noggin and antagonists of bone morphogenetic proteins to suppress pathologic bone resorption
ES2639020T3 (es) * 1998-11-27 2017-10-25 Ucb Pharma S.A. Composiciones y métodos para incrementar la mineralización de la substancia ósea
US6727224B1 (en) 1999-02-01 2004-04-27 Genetics Institute, Llc. Methods and compositions for healing and repair of articular cartilage
EP1223990B1 (en) 1999-10-15 2004-07-28 Genetics Institute, LLC Formulations of hyaluronic acid for delivery of osteogenic proteins
US7226587B2 (en) 2001-06-01 2007-06-05 Wyeth Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins
WO2002099134A1 (en) * 2001-06-05 2002-12-12 Auckland Uniservices Limited Methods and compositions for assessment of pulmonary function and disorders
EP1399177A1 (en) * 2001-06-08 2004-03-24 Smith & Nephew PLC Bmp binding proteins for use in bone or cartilage regeneration
TWI267378B (en) 2001-06-08 2006-12-01 Wyeth Corp Calcium phosphate delivery vehicles for osteoinductive proteins
GB2385052A (en) * 2002-02-05 2003-08-13 Leuven K U Res & Dev Treatment of spondyloarthropathies
US7193069B2 (en) * 2002-03-22 2007-03-20 Research Association For Biotechnology Full-length cDNA
US20060276385A1 (en) * 2003-01-13 2006-12-07 Hanjoong Jo Anti-inflammatory agents and methods of their use
EP1755648A2 (en) * 2004-05-27 2007-02-28 Acceleron Pharma Inc. Cerberus/coco derivatives and uses thereof
US9045553B2 (en) 2004-05-27 2015-06-02 Acceleron Pharma, Inc. Cerberus/Coco derivatives and uses thereof
EP1896607A4 (en) * 2005-05-10 2009-12-16 Synergenz Bioscience Ltd METHOD AND COMPOSITIONS FOR THE ASSESSMENT OF LUNG FUNCTION AND RESPIRATORY DISEASE
JP2008545390A (ja) * 2005-05-19 2008-12-18 シナージェンズ バイオサイエンス リミティド 遺伝的多型を用いた肺癌を発達させるリスクの評価方法
WO2006123954A1 (en) * 2005-05-19 2006-11-23 Synergenz Bioscience Limited Methods and compositions for assessment of pulmonary function and disorders
WO2006123943A1 (en) * 2005-05-20 2006-11-23 Synergenz Bioscience Limited Methods of analysis of polymorphisms and uses thereof
US20090298761A1 (en) * 2006-05-17 2009-12-03 Donald Engelman Methods of treating cartilage defects using a soluble morphogenic protein complex
JP2010512326A (ja) * 2006-12-08 2010-04-22 アクセルロン ファーマ， インコーポレイテッド Ｃｅｒｂｅｒｕｓ、Ｃｏｃｏおよびこれらの誘導体の使用
CN105759056B (zh) * 2016-04-06 2017-11-14 四川大学华西医院 一种肺癌筛查试剂盒
US10961305B2 (en) 2016-12-21 2021-03-30 Mereo Biopharma 3 Limited Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfecta

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4952499A (en) * 1988-02-11 1990-08-28 Dana-Farber Cancer Institute Genes and their encoded proteins which regulate gene expression of the interleukin-2 receptor and of human lymphotropic retroviruses
US6133232A (en) * 1996-06-20 2000-10-17 The Regents Of The University Of California Endoderm, cardiac and neural inducing factors

Also Published As

Publication number Publication date
AU6873698A (en) 1998-11-24
US7241739B2 (en) 2007-07-10
NZ500577A (en) 2001-02-23
AU726385B2 (en) 2000-11-02
JP2001526535A (ja) 2001-12-18
JP4062551B2 (ja) 2008-03-19
WO1998049296A1 (en) 1998-11-05
EP0975752A1 (en) 2000-02-02
US20030199042A1 (en) 2003-10-23
US6610510B1 (en) 2003-08-26
CA2288373C (en) 2010-06-01
CA2288373A1 (en) 1998-11-05

Similar Documents

Publication Publication Date Title
AU6030398A (en) Human proteins
AU5721798A (en) Human mage-like protein
AU4480697A (en) Human nm23-like protein
GB9703681D0 (en) Protein complemention
GB9719879D0 (en) Protein
AU2095299A (en) Human signal peptide-containing proteins
AU2205499A (en) Human regulatory proteins
AU9017598A (en) Human frezzled-like protein
GB9715064D0 (en) Protein expression
ZA984322B (en) Sucrose-binding proteins
AU6056898A (en) Human lea-motif developmental protein
AU4992099A (en) Human presenilin-associated protein
GB9720784D0 (en) Protein
AU7135398A (en) Human rho protein
GB9519865D0 (en) Protein
AU6050198A (en) Novel human cystatin-like protein
AU2593199A (en) Human smn-like protein
AU7259898A (en) Human smt-3 like protein
AU9376598A (en) Human (act)va-orf4-like protein
GB9622436D0 (en) Protein
AU6164198A (en) Novel human parvulin-like protein
IL139595A0 (en) Human protein c polypeptide
HK1024930A (en) Human cerberus protein
AU7285298A (en) Human tsc-22-like protein
AU6689898A (en) Novel human mlf3 protein